Transdermal Drug Delivery – Is it feasible for your drug?
This web seminar shows the components of a TTS, and how it can be used to provide a genuine alternative to current drug delivery methods. In this sense, this presentation aims to ascertain whether TTS should be chosen as a first choice dosage form.
Language: EN Presented by Dr. Peter Klaffenbach, Head of Pharmaceutical Development & Dr. Iris Schnitzler, Director Marketing and Market Services
